HealthEquity, Inc.
HQY Healthcare Health Information Services
HealthEquity, Inc.’s revenue for fiscal 2026 (year ended January 2026) was $1.3 billion, up 9.47% from fiscal 2025. In the quarter to July 2026, revenue grew 7.64%, EPS grew 14.5%, free cash flow fell 3.44% and total debt fell 7.53%, each against the same quarter a year earlier. Revenue growth for ten consecutive years, operating cash flow growth for three.
Follow HQY
HealthEquity, Inc. (HQY) EV/Sales
As of 16 October 2026, HealthEquity, Inc. (HQY) trades at a EV/Sales of 6.1×. Over the past ten years it has ranged from 4.8× (December 2021) to 22.2× (September 2018); the current reading is higher than 7% of that period. That is above the Health Information Services industry median of 2.6× and above the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2026 | 6.2× | (28.16%) |
| FY2025 | 8.6× | 24.22% |
| FY2024 | 7.0× | 3.22% |
| FY2023 | 6.7× | (0.93%) |
| FY2022 | 6.8× | (27.47%) |
| FY2021 | 9.4× | (8.53%) |
| FY2020 | 10.3× | (15.66%) |
| FY2019 | 12.2× | (0.74%) |
| FY2018 | 12.3× | (13.64%) |
| FY2017 | 14.2× | 66.15% |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jul 2026 | 6.7× | 17.00% |
| Apr 2026 | 5.7× | (8.24%) |
| Jan 2026 | 6.2× | (9.18%) |
| Oct 2025 | 6.8× | (4.83%) |
| 43 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| BTSG BrightSpring Health Services, Inc. compare | 1.0× |
| PRVA Privia Health Group, Inc. compare | 1.0× |
| WAY Waystar Holding Corp. compare | 5.4× |
| HQY HealthEquity, Inc. | 6.1× |
| DOCS Doximity, Inc. compare | 7.6× |
| TEM Tempus AI, Inc. compare | 8.5× |
| HNGE Hinge Health Inc. compare | 10.3× |
| TXG 10x Genomics compare | 13.9× |
| HTFL Heartflow, Inc. compare | 19.8× |
| Health Information Services industry median | 2.6× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)